కమ్యూనిటీ & పబ్లిక్ హెల్త్ నర్సింగ్ జర్నల్

నైరూప్య

Using Mesenchymal Stem Cells to Treat Female Infertility: An Update on Female Reproductive Diseases A Review Article

Shikha Gupta, Danish Kumar and Manju Rajput

Female physiological state impacts the Female physiological state impacts the standard of life and well-being
of affected people and couples. Feminine procreative diseases, like primary female internal reproductive organ
insufficiency, polycystic ovary syndrome, adenomyosis, Fallopian tube obstruction, and as her man syndrome, will
induce physiological state. In recent years, translational drugs have developed quickly, and clinical researcher’s area
unit that specializes in the treatment of feminine physiological state exploitation novel approaches. Thanks to the
benefits of convenient samples, abounding sources, and avertible moral problems, mesenchymal stem cells (MSCs)
will be applied wide within the clinic. This paper reviews recent advances in exploitation four kinds of MSCs, bone
marrow stromal cells, adipose-derived stem cells, menstrual flow mesenchymal stem cells, and duct mesenchymal
stem cells. every of those are used for the treatment of female internal reproductive organ and female internal
reproductive organ diseases, and supply new approaches for the treatment of feminine physiological state’s quality
of life and well-being of affected people and couples. Feminine procreative diseases, like primary female internal
reproductive organ insufficiency, polycystic ovary syndrome, adenomyosis, Fallopian tube obstruction, and Asherman
syndrome, will induce physiological state. In recent years, a translational drug has developed quickly, and clinical
researcher’s area unit that specializes in the treatment of feminine physiological state exploitation novel approaches.
Thanks to the benefits of convenient samples, abounding sources, and avertible moral problems, mesenchymal stem
cells (MSCs) will be applied wide within the clinic. This paper reviews recent advances in exploitation four kinds of
MSCs, bone marrow stromal cells, adipose-derived stem cells, menstrual flow mesenchymal stem cells, and duct
mesenchymal stem cells. Every of those are used for the treatment of female internal reproductive organ and female
internal reproductive organ diseases, and supply new approaches for the treatment of feminine physiological state.